-
OPEC+ hikes oil production by more than expected following outbreak of Iran war
-
Goggia tightens grip on World Cup super-G with victory in Andorra
-
Belgium seizes Russian 'shadow fleet' tanker
-
Raza steers Zimbabwe to 153-7 against South Africa
-
Kerr on target as Australia make winning start to Women's Asian Cup
-
Marquez says 'unlucky' to retire from MotoGP season opener
-
9 killed in pro-Iran protest at US consulate in Pakistan's Karachi
-
Green clinches Singapore title with help from caddie husband
-
More flights cancelled as Iran conflict shuts Mideast hubs
-
'One Battle After Another' wins top producer award before Oscars
-
Iran vows revenge for slain supreme leader despite Trump threat
-
Flights of fancy at Bottega Veneta with shimmering, tactile collection
-
World Cup marks 100-day countdown amid political upheaval
-
Bezzecchi wins MotoGP opener as Marquez retires
-
Pro-Iran protesters try to storm US missions in Pakistan, Iraq
-
8 killed in pro-Iran protest at US consulate in Pakistan's Karachi
-
Latest developments after US, Israeli strikes kill Iran's Khamenei
-
Before dawn, ancient drum rite wakes Istanbul faithful to fast
-
Music, mourning as Iran's Khamenei is killed
-
Pakistan cricket's lack of T20 evolution exposed by World Cup exit
-
Cobolli downs Tiafoe to claim Mexican Open
-
Takele defends Tokyo Marathon title after sprint finish
-
Hollywood's finest gather for guild's Actor Awards
-
Iran prepare for Women's Asian Cup as bombs drop on homeland
-
Doncic shines as Lakers cruise past depleted Warriors
-
3D tool Unreal Engine makes real impact in creative industries
-
OPEC+ mulls oil production increase in shadow of war
-
Putin, Russia's eternal leader defined by war and power
-
Explosion, gunfire as Afghan forces shoot at aircraft over Kabul
-
Iranians across North America rally for -- and against -- strikes
-
Shakespeare would have shunned streaming, 'Hamnet' team says
-
Will Oscars be 17th time lucky for songwriter Diane Warren?
-
Sympathy for the bedeviled: the likable conspiracy theorist of 'Bugonia'
-
Texas port humming as Trump ramps up Venezuela oil
-
76ers' center Embiid to miss at least three games with oblique strain
-
US, Israel defend strikes at UN as Iran alleges 'war crime'
-
Brumbies' 'mental resolve' keeps them unbeaten in Super Rugby
-
Iran attacks rock Dubai's Palm, Burj Al Arab, airport
-
JP Anderson Signs Landmark MOU with Vaama Village to Advance Rare Earth Mineral Development in Bonthe District
-
Iran leader Khamenei killed in massive US and Israeli attack, Trump says
-
UK pop-soul star Olivia Dean sweeps Brit Awards
-
Iranians across North America take to the streets for - and against - strikes
-
'Turning point' as Crusaders notch first Super Rugby win
-
White House releases photos of Trump, Vance during Iran ops
-
PSG win to extend lead over Lens at top of Ligue 1
-
Barca's Yamal nets hat-trick in Villarreal romp, Atletico go third
-
Trump says Khamenei is dead after Israel, US attack Iran
-
Iran's Khamenei: ruthless revolutionary atop Islamic republic
-
Inter continue Scudetto march after Champions League humbling
-
Questions cloud Trump's case for war against Iran
Brazilian ritual root gets second life as potential anti-depressant
Long used in Indigenous Brazilian rituals, the jurema preta plant, which contains a potent psychedelic, is gaining ground as a potential treatment for depression.
At street stalls where medicinal herbs are sold, customers can buy the plant's root which contains dimethyltryptamine (DMT), a hallucinogenic substance that researchers say could be used to alleviate symptoms.
Following instructions he found on the internet, Guaracy Carvajal extracted DMT at home in 2016 from roots he bought on the street.
The 31-year-old software programmer, who had tried various treatment for chronic depression he has suffered since adolescence, said the drug makes it "feel like you've solved something in your life."
Physicist Draulio Araujo, who has conducted extensive research on the drug, said "the response is rapid. One day after treatment, (patients) already showed a significant improvement in their depression symptoms."
Yet he also warned that it "is not a magic cure" and that psychedelics "are not for everyone."
As a researcher at the Brain Institute of the Federal University of Rio Grande do Norte, Araujo and his team treated 14 people with the drug for six months.
The patients inhaled vaporized DMT, under medical supervision.
"It's common for our patients to say that something changed, that a key opened something," he said.
His patients also received psychological therapy, and some continued with conventional pharmaceutical drugs.
Neuroscientist Fernanda Palhano-Fontes, also of the Brain Institute, said "we have patients who improve significantly, others who don't improve at all."
Araujo's findings were published in the scientific journal Nature in April. In 2024, he published another study with promising results in the journal Psychedelic Medicine.
As for Carvajal, who stopped using jurema preta some time ago, he said the drug really allows a person to "start to have a lighter life."
It helped him get through a time when he was in "a state of questioning myself" about "work, day-to-day life," he said.
- Spiritual channels -
Brazil occupies a fairly prominent place in DMT research due to the substance's prominence in society, Araujo said.
While there is no ban on the cultivation or possession of jurema, which is also known as Mimosa tenuiflora, consumption of DMT is prohibited, except for religious and scientific use.
Jurema's roots are combined with other plants in a wine-like beverage that is consumed at rituals that include dancing and drums, part of Indigenous tradition in northeast Brazil where the plant grows.
"It's not hallucination," said Joyce Souza, a young woman attending a jurema ceremony in Planaltina, on the outskirts of Brasília.
"My spiritual channels become more accessible, I can communicate better with myself," Souza said.
Gathered in a house courtyard and dressed in white, the group of mostly novices waited for more seasoned practitioners to enter a trance and bring messages from ancient spirits.
Meanwhile, back in the lab, Araujo is hoping to expand his DMT research to a study of 100 patents.
"Let's say that in five years we'll have... a clear picture on when it will reach a real clinical setting," he said.
A.Malone--AMWN